Ann: Mesoblast Healthcare Conference Investor Presentation, page-35

Have to agree with your critics this time Gan_Gans. You need to qualify your criticism. You've suggested ambiguity by being a bit ambiguous yourself. That doesn't really qualify as evidence. If you have some genuine constructive insights as to where the data or assertions are at all flawed then it serves purpose for shorts and longs alike..

Look forward to your constructive and insightful criticisms so we can avail ourselves of your knowledge. I am not being smart. Counter objective arguments are always worthwhile for all.